ECRETO DEL DIRETTORE GENERALE - N. 121-DG del 20/02/2025 - Allegato Utente 2 (A02)Standard Contractual Clauses • January 17th, 2025
Contract Type FiledJanuary 17th, 2025STANDARD CONTRACTUAL CLAUSES CLAUSOLE CONTRATTUALI TIPO These Standard Contractual Clauses are entered into in relation to the Agreement for the Conduct of Clinical Trials for the study AB-106-G208 A Single- Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of Taletrectinib in Patients with Advanced or Metastatic ROS1 Positive NSCLC and Other Solid Tumors”, concerning Protocol No. AB-106-G208 (version No. 2 dated 09 Novembre 2021 and its subsequent duly approved amendments, EU Clinical Trial No. 2021- 003091-14) (hereafter the “Agreement”) signed by and between Fondazione IRCCS Istituto Nazionale Dei Tumori, with registered office in Milan, via Venezian 1, 20133 Milan, Italy, Cod. Fisc. no. 80018230153 and V.A.T. no. 04376350155 in theperson of the Director General Dr. Maria Teresa Montella (hereinafter referred to as the “Entity” or “Data Exporter”) and AnHeart Therapeutics LLC (f/k/a AnHeart Therapeutics Inc.) with an office at 1500 Broadway, Suite 1401,